SVB Wealth’s Exact Sciences EXAS Stock Holding History

SVB Wealth’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-697	Closed	-$30.2K	–	892
2025 Q1	$30.2K	Buy	+697	New	+$35.3K	﹤0.01%	659

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

SVB Wealth's EXAS Position: Q2 2025 in Review

SVB Wealth sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 697 shares — an estimated $30.2K sold.

SVB Wealth first reported a position in EXAS in Q1 2025 and held it in 1 quarter. The position peaked at $30.2K in Q1 2025. 557 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

SVB Wealth reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
SVB Wealth sold 697 Exact Sciences shares in Q2 2025, an estimated $30.2K.
SVB Wealth first reported a position in Exact Sciences in Q1 2025 and held it in 1 quarter.
SVB Wealth's Exact Sciences position peaked at $30.2K in Q1 2025.
557 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.